Meyers JL, Davis KL, Yu YF. Stroke and transient ischemic attack in the long-term care setting: patient characteristics, medication treatment, and length of stay. Consult Pharm. 2011 Mar 1;26(3):170-81.
Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.